Search Results for 'critical congenital heart disease'
-
FDA Clears Masimo's Neonatal RD SET Pulse Oximetry Sensors with Improved Accuracy Specifications
Improved oxygen saturation accuracy now available for all patient populations.Business Wire 01.02.20
-
Patient Monitoring
Masimo Unveils Newborn Oxygenation Visualization Technology
Pathway provides clinicians with a way to visualize a hospital’s recommended resuscitation protocol for a newborn’s oxygen saturation.Business Wire 10.16.19
-
Patient Monitoring
Masimo Gains CE Mark for Neonatal Noninvasive Continuous Hemoglobin Monitoring
With this clearance, the benefits of SpHb are available for patients of all ages in CE mark countries.Business Wire 08.05.19
-
Patient Monitoring
FDA OKs Neonatal Indication for Masimo's O3 Regional Oximetry
The benefits of monitoring with O3 are now available to patients of all ages, from neonates to adults.Business Wire 06.10.19
-
Patient Monitoring
FDA Clears Masimo's Radius PPG, the First Tetherless SET Pulse Oximetry Sensor Solution
Radius PPG is suited for use anywhere patients can benefit from mobility.Business Wire 05.16.19
-
Patient Monitoring
Masimo & Mindray Expand Partnership
Mindray to offer Masimo SET pulse oximetry in its patient monitoring devices in additional countries beyond the United States.Business Wire 05.13.19
-
FDA Clears Masimo RD Sensors With Improved Accuracy Specifications for SET Pulse Oximetry
The RD SET sensors are designed to enhance patient comfort, optimize clinician workflows, and help hospitals meet green initiatives.Business Wire 12.11.18
-
Masimo Announces CE Marking of Eve CCHD Newborn Screening Application
The application is designed to be used with the company's Rad-97 Pulse CO-Oximeter.Business Wire 02.28.18
